Results 21 to 30 of about 57,195 (184)

mTOR inhibition by TAK‐228 is effective against growth, survival and angiogenesis in preclinical retinoblastoma models

open access: yesPharmacology Research & Perspectives, 2022
We and others have shown that aberrant activation of the mammalian target of rapamycin (mTOR) signalling is essential for retinoblastoma progression and has potential therapeutic value.
Lanlan Tang   +5 more
doaj   +1 more source

CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis [PDF]

open access: yes, 2016
Retinoblastoma is a pediatric eye tumor in which bi-allelic inactivation of the Retinoblastoma 1 (RB1) gene is the initiating genetic lesion. Although recently curative rates of retinoblastoma have increased, there are at this time no molecular targeted ...
Boel, Annekatrien   +12 more
core   +2 more sources

Retinoblastoma

open access: yesThe Lancet, 2012
Retinoblastoma is an aggressive eye cancer of infancy and childhood. Survival and the chance of saving vision depend on severity of disease at presentation. Retinoblastoma was the first tumour to draw attention to the genetic aetiology of cancer. Despite good understanding of its aetiology, mortality from retinoblastoma is about 70% in countries of low
Gallie Brenda L.   +6 more
openaire   +3 more sources

Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies

open access: yesIndian Journal of Ophthalmology, 2023
Retinoblastoma is a retinal cancer that affects children and is the most prevalent intraocular tumor worldwide. Despite tremendous breakthroughs in our understanding of the fundamental mechanisms that regulate progression of retinoblastoma, the ...
Shruti Rathore   +8 more
doaj   +1 more source

Retinoblastoma

open access: yesJournal of Education, Health and Sport, 2018
Budny Agnieszka, Grochowski Cezary. Retinoblastoma. Journal of Education, Health and Sport. 2018;8(7):204-213. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1299573 http://ojs.ukw.edu.pl/index.php/johs/article/view/5611 https://pbn.nauka.gov.pl/sedno-webapp/works/868825 The journal has had 7 points in Ministry of Science and ...
Agnieszka Budny, Cezary Grochowski
openaire   +4 more sources

BTG interacts with retinoblastoma to control cell fate in Dictyostelium. [PDF]

open access: yes, 2010
In the genesis of many tissues, a phase of cell proliferation is followed by cell cycle exit and terminal differentiation. The latter two processes overlap: genes involved in the cessation of growth may also be important in triggering differentiation ...
Ceccarelli, Adriano   +2 more
core   +7 more sources

Retinoblastoma and vision [PDF]

open access: yesEye, 2022
AbstractThe assessment of vision has a growing importance in the management of retinoblastoma in the era of globe-conserving therapy, both prior to and after treatment. As survival rates approach 98–99% and globe salvage rates reach ever-higher levels, it is important to provide families with information regarding the visual outcomes of different ...
Omar Warda   +4 more
openaire   +3 more sources

Retinoblastoma in Late Childhood

open access: yesJournal of Nepal Medical Association, 2003
Retinoblastoma, the commonest intra-ocular tumor of childhood, is rare after the age of 5 years. We report a case of retinoblastoma in a 10 year-old boy, who presented with a fungating proptosed tender mass involving the entire left eye and the orbit.
B Badhu, S P Sah, S Kumar, R P Sah
doaj   +1 more source

Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. [PDF]

open access: yes, 2017
A small, but unique subgroup of retinoblastoma has been identified with no detectable mutation in the retinoblastoma gene (RB1) and with high levels of MYCN gene amplification.
Bhatti, Tricia R.   +6 more
core   +2 more sources

Update on pathology of retinoblastoma [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
Retinoblastoma is caused by mutational inactivation of both alleles of the RB1 gene, which maps to chromosome 13q14 and encodes retinoblastoma protein that acts as a tumor suppressor.
Lata Singh, Seema Kashyap
doaj   +1 more source

Home - About - Disclaimer - Privacy